Session Details
[S05☆]Establishing a Shared Industry-Academia Understanding to Ensure the Reliability of Nonclinical Study Results: Toward Delivering Better Medicines to Patients Even Sooner
Fri. Mar 27, 2026 9:30 AM - 11:30 AM JST
Fri. Mar 27, 2026 12:30 AM - 2:30 AM UTC
Fri. Mar 27, 2026 12:30 AM - 2:30 AM UTC
Room 09 (B401)
Organizer: Emiko Takeuchi (GLP, JSQA), Hiromi Takano-Ohmuro (Fac. Pharm., Musashino Univ., GLP, JSQA)
オーガナイザー挨拶(趣旨・背景説明)
大室 弘美1,2(1日本QA研GLP,2武蔵野大薬)
[S05-1]Survey on research integrity education received during the academic years of newly hired science and engineering graduates
○Hideki Kozono1, Isao Watanabe1, Hiromi Takemoto1, Rie Sonoda1, Ayumi Ishiyama1, Kazunori Narumi1, Tamaki Wada1, Takayuki Kato1, Koji Ueshima1, Emiko Takeuchi1, Hiromi Takano-Ohmuro1,2 (1. GLP, JSQA, 2. Fac. Pharm., Musashino Univ.)
[S05-2]Identification of essential laboratory notebook entries for ensuring the reliability of test results and development of a laboratory notebook template
○Koji Ueshima1, Rie Sonoda1, Hiromi Takemoto1, Ayumi Ishiyama1, Kazunori Narumi1, Tamaki Wada1, Hideki Kozono1, Takayuki Kato1, Emiko Takeuchi1, Hiromi Takano-Ohmuro1,2 (1. GLP, JSQA, 2. Fac. Pharm., Musashino Univ.)
[S05-3]Development of a practical guide for ensuring the reliability of nonclinical pharmacology studies conducted in academia
○Hitoshi Kawano1, Sumiko Nagaki1, Emiko Takeuchi1, Koji Ueshima1, Takayuki Kato1, Ai Yakiwara1, Masato Sakaguchi1, Daisuke Sugiyama1,2, Chika Akagi1, Koki Murakami1, Miyuki Yamamoto1, Mutsumi Suzuki3, Toru Ogawa3, Hiromi Takano-Ohmuro1,4 (1. GLP, JSQA, 2. TRC, Hiroshima Univ., 3. Non-Clinical Evaluation Expert, Drug Evaluation, JPMA, 4. Fac. Pharm., Musashino Univ.)
[S05-4]Survey results and future academia–industry collaboration to improve the reliability of nonclinical pharmacology studies
○Sumiko Nagaki1, Daisuke Sugiyama1,2, Emiko Takeuchi1, Chika Akagi1, Ai Yakiwara1, Masato Sakaguchi1, Koki Murakami1, Takayuki Kato1, Miyuki Yamamoto1, Toru Ogawa3, Mutsumi Suzuki3, Hitoshi Kawano1, Koji Ueshima1, Hiromi Takano-Ohmuro1,4 (1. GLP, JSQA, 2. TRC, Hiroshima University, 3. Non-Clinical Evaluation Expert, Drug Evaluation, JPMA, 4. Fac. Pharm., Musashino Univ.)
